In fact, BCL-XL is a strong PDAC dependency compared with MCL1 and BCL2 across 45 PDAC cell lines in the Cancer Dependency Map (DepMap), a library of genome-wide CRISPR/Cas9 loss-of-function screens39 (Supplementary Fig. 9e). Here, BCL2 is linked to cancer.